1. CMC postapproval manufacturing changes for specified biological products to be documented in annual reports Publication: Silver Spring, MD : Center for Drug Evaluation and Research, December 2021 Subject(s): Biological Products -- chemistryBiological Products -- supply & distributionUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
